C

CeriBell Inc
NASDAQ:CBLL

Watchlist Manager
CeriBell Inc
NASDAQ:CBLL
Watchlist
Price: 20.93 USD 2.55% Market Closed
Market Cap: 776.5m USD

Wall Street
Price Targets

CBLL Price Targets Summary
CeriBell Inc

Wall Street analysts forecast CBLL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CBLL is 25.21 USD with a low forecast of 17.17 USD and a high forecast of 33.6 USD.

Lowest
Price Target
17.17 USD
18% Downside
Average
Price Target
25.21 USD
20% Upside
Highest
Price Target
33.6 USD
61% Upside
CeriBell Inc Competitors:
Price Targets
TMDX
Transmedics Group Inc
16% Upside
688351
Shanghai MicroPort EP Medtech Co Ltd
14% Upside
LNSR
LENSAR Inc
33% Upside
853
Microport Scientific Corp
45% Upside
LUCD
Lucid Diagnostics Inc
230% Upside
6951
JEOL Ltd
29% Upside
9996
Peijia Medical Ltd
59% Upside

Revenue
Forecast

Revenue Estimate
CeriBell Inc

For the last 1 year the compound annual growth rate for CeriBell Inc's revenue is 45%. The projected CAGR for the next 4 years is 31%.

45%
Past Growth
31%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
CeriBell Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
CeriBell Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CBLL's stock price target?
Price Target
25.21 USD

According to Wall Street analysts, the average 1-year price target for CBLL is 25.21 USD with a low forecast of 17.17 USD and a high forecast of 33.6 USD.

What is CeriBell Inc's Revenue forecast?
Projected CAGR
31%

For the last 1 year the compound annual growth rate for CeriBell Inc's revenue is 45%. The projected CAGR for the next 4 years is 31%.

Back to Top